patient characteristics and receipt of appropriate care in a sample of patients treated with buprenorphine for their opioid use disorders in a primary care setting. Method: This study used retrospective ... clinical…
patients who are deemed appropriate for medication-assisted treatment (MATx) of opioid dependence Buprenorphine/naloxone (bupe/nx) became a second option for patients in the United States suffering from opioid…
Background: Opioid agonist therapy with buprenorphine is an effective, evidence-based treatment for opioid use disorder. However, there has been increasing use of alternative substances which can still produce opioid…
patient characteristics, and receipt of appropriate care in a sample of patients treated with buprenorphine for their opioid use disorders in a primary care setting. METHODS This study used retrospective ... clinical…
Background: Mono-buprenorphine has been the most abused intravenous opioid in Finland since 2001. A buprenorphine/naloxone combination drug intended to lower the risk of abuse became already available ... Finland in…
Objective: This study aimed to evaluate and compare the safety of CIII buprenorphine and oral CII opioids among Medicare patients with chronic Low-Back Pain (cLBP). Methods: The retrospective study ... conducted in…
Currently, there is no consensus on continuing vs. holding buprenorphine preoperatively. Management of post-operative pain in patients on buprenorphine has been hotly debated, with evidence showing for and against…
Pregnant women who are addicted on opioids are frequently treated with buprenorphine, a semi-synthetic opioid. Pregnancy-related buprenorphine pharmacokinetics is little studied. To find out the pharmacokinetics of…
Background: Buprenorphine is a partial mu-opioid agonist and kappa antagonist, whereas Naltrexone is a competitive μ receptor antagonist. Buprenorphine’s partial agonist activity can induce withdrawal in opioid…
Buprenorphine and Fentanyl transdermal patches are used for the management of chronic intractable pain in both malignant and nonmalignant patients. Both Buprenorphine and fentanyl are potent opioids, but they have…
patient characteristics and receipt of appropriate care in a sample of patients treated with Buprenorphine for their opioid use disorders in a primary care setting. Methodology & Theoretical Orientation: This study…
block. Present study was undertaken to compare the efficacy of intrathecal fentanyl or buprenorphine with bupivacaine for all infraumbilical surgeries. MATERIALS AND METHODS 100 ASA I and II patients ... fentanyl and…
Background: Buprenorphine administration is accompanied with speedy-acting antidepressant effects. Objective: To describe the antidepressant potentials of buprenorphine. Discussion: Buprenorphine has rapid-acting and…
chronic, relapsing condition leading to significant morbidity and mortality. Since the advent of buprenorphine/naloxone pharmacotherapy with its US FDA approval in 2002, its use has expanded ... been found to decrease…
Transdermal buprenorphine is an opioid analgesic used in the management of moderate-severe pain via transdermal pathway. The case series is to discuss the efficacy and safety of transdermal buprenorphine ... chronic…
assessed using the scale to assess satisfaction with medications for addiction treatmentâÂ?Â?buprenorphine/naloxone for heroin addiction (SASMAT-BUNHER). Satisfaction with other treatment interventions was explored…
opioid use disorder and unsupportable demand for enrollment in opioid assisted treatment (OAT) via buprenorphine/naloxone (Suboxone®) or methadone treatment programs. In July 2016, the Department of Health and Human…
Objectives: The geographical distribution of Ohio physicians listed on the Buprenorphine Treatment and Physician Locator published by SAMHSA was analyzed to evaluate availability and accessibility from the patient…
required to develop new medications. Objective: To test the efficacy of low dose of buprenorphine on the reduction or cessation of alcohol withdrawal craving. Method: To evaluate the competence ... four mg of…
Background: Buprenorphine is a partial mu-opioid receptor agonist that is an effective agent for agonist therapy for opioid addiction and for the management of withdrawal from heroin and other ... opioids. Methods: 379…
Buprenorphine, a highly effective yet underutilized medication for opioid dependence, is crucial to tackling the current global opioid epidemic. Multiple studies have identified the need for more clinical information…
Opioid use disorder has emerged as a global healthcare crisis. Buprenorphine is has become the standard treatment. Unfortunately, buprenorphine has a relatively high failure rate, as well as a lengthy ... course of…
Objective: To assess long-term exposure to buprenorphine implants (BIs) for opioid dependence in two open-label extension clinical trials. Methods: Two six-month, open-label, multicenter extension studies ... prior…
foetus. The main medications in treatment of opioid use disorder are methadone, naltrexone and buprenorphine products. Naloxone (pregnancy class: B) was carefully selected to be a part of Suboxone ... ratio to…
Objective: To illuminates the efficacy of a single dose of 66 mg of sublingual buprenorphine in the treatment of heroin dependence. Results: Admini stration of a single dose ... buprenorphine is quite effective in the…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.